Practice guidelines and clinical governance: do the means match with the ends? A quality appraisal of local practice guidelines

(The) AGREE Collaboration (2003), “Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project”, Quality and Safety in Health Care, Vol. 12, February, pp. 18‐23.

AGREE Collaborative Group (2001), “Guideline development in Europe”, International Journal of Technology Assessment in Health Care, Vol. 16, pp. 1039‐49.

Choudhry, N.K., Stelfox, H.T. and Detsky, A.S. (2002), “Relationships between authors of clinical practice guidelines and the pharmaceutical industry”, Journal of the American Medical Association, Vol 287 No. 5, pp. 612‐17.

Graham, I.D., Beardall, S., Carter, A.O., Glennie, J., Hebert, P.C., Tetroe, J.M., McAlister, F.A., Visentin, S. and Anderson, G.M. (2001), “What is the quality of drug therapy clinical practice guidelines in Canada?”, Canadian Medical Association Journal, Vol. 165 No. 2, pp. 157‐63.

Grilli, R., Magrini, N., Penna, A., Mura, G. and Liberati, A. (2000), “Practice guidelines developed by specialty societies: the need for a critical appraisal”, Lancet, Vol. 355 No. 9198, pp. 103‐6.

Grimshaw, J. and Russell, I. (1993), “Achieving health gain through clinical guidelines. I: developing scientifically valid guidelines”, Quality in Health Care, Vol. 2 No. 4, pp. 243‐8.

Miller, J. and Petrie, J. (2001), “Development of practice guidelines”, Lancet, Vol. 355 No. 9198, pp. 82‐3.

Secretary of State for Health (1998), A First‐Class Service, Department of Health, London.

Shaneyfelt, T.M., Mayo‐Smith, M.F. and Rothwangl, J. (1999), “Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer‐reviewed medical literature”, Journal of the American Medical Association, Vol. 281 No. 20, pp. 1900‐5.